Literature DB >> 32717031

C/EBPβ isoforms sequentially regulate regenerating mouse hematopoietic stem/progenitor cells.

Atsushi Sato1, Naoka Kamio1, Asumi Yokota1,2, Yoshihiro Hayashi1,2,3, Akihiro Tamura1, Yasuo Miura1, Taira Maekawa1, Hideyo Hirai1.   

Abstract

The transcription factor CCAAT enhancer-binding protein β (C/EBPβ) is required for stress-induced granulopoiesis at the level of hematopoietic stem/progenitor cells (HSPCs); however, its role and mechanisms of action in HSPCs are unknown. In this study, we assessed the regulation and functions of C/EBPβ in HSPCs, especially under stress conditions. After 5-fluorouracil treatment or bone marrow transplantation, Cebpb-/- HSPCs exhibited impaired cell-cycle activation and myeloid differentiation at the early and late phases of regeneration, respectively, whereas at steady state, Cebpb deficiency did not affect HSPCs. C/EBPβ was upregulated in response to hematopoietic stress, especially in CD150high long term-hematopoietic stem cells (LT-HSCs). Intracellular flow cytometric analysis that detected distinct domains of C/EBPβ revealed that, among the 3 isoforms of C/EBPβ, liver-enriched inhibitory protein (LIP) was upregulated in LT-HSCs prior to liver-enriched activating protein (LAP)/LAP* during regeneration. Early upregulation of LIP promoted cell-cycle entry of LT-HSCs by positively regulating Myc and expanded the HSPCs pool. Subsequent myeloid differentiation of amplified HSPCs was mediated by LAP/LAP*, which were upregulated at a later phase of regeneration. Collectively, our findings show that stress-induced sequential upregulation of C/EBPβ isoforms is critical for fine-tuning the proliferation and differentiation of regenerating HSPCs.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32717031      PMCID: PMC7391146          DOI: 10.1182/bloodadvances.2018022913

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  40 in total

Review 1.  Balancing dormant and self-renewing hematopoietic stem cells.

Authors:  Anne Wilson; Elisa Laurenti; Andreas Trumpp
Journal:  Curr Opin Genet Dev       Date:  2009-10-05       Impact factor: 5.578

2.  Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow.

Authors:  Alejandro B Balazs; Attila J Fabian; Charles T Esmon; Richard C Mulligan
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

3.  Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis.

Authors:  Nina Cabezas-Wallscheid; Daniel Klimmeck; Jenny Hansson; Daniel B Lipka; Alejandro Reyes; Qi Wang; Dieter Weichenhan; Amelie Lier; Lisa von Paleske; Simon Renders; Peer Wünsche; Petra Zeisberger; David Brocks; Lei Gu; Carl Herrmann; Simon Haas; Marieke A G Essers; Benedikt Brors; Roland Eils; Wolfgang Huber; Michael D Milsom; Christoph Plass; Jeroen Krijgsveld; Andreas Trumpp
Journal:  Cell Stem Cell       Date:  2014-08-21       Impact factor: 24.633

4.  C/EBPβ is involved in the amplification of early granulocyte precursors during candidemia-induced "emergency" granulopoiesis.

Authors:  Sakiko Satake; Hideyo Hirai; Yoshihiro Hayashi; Nobuaki Shime; Akihiro Tamura; Hisayuki Yao; Satoshi Yoshioka; Yasuo Miura; Tohru Inaba; Naohisa Fujita; Eishi Ashihara; Jiro Imanishi; Teiji Sawa; Taira Maekawa
Journal:  J Immunol       Date:  2012-09-28       Impact factor: 5.422

5.  mTORC1 Activation during Repeated Regeneration Impairs Somatic Stem Cell Maintenance.

Authors:  Samantha Haller; Subir Kapuria; Rebeccah R Riley; Monique N O'Leary; Katherine H Schreiber; Julie K Andersen; Simon Melov; Jianwen Que; Thomas A Rando; Jason Rock; Brian K Kennedy; Joseph T Rodgers; Heinrich Jasper
Journal:  Cell Stem Cell       Date:  2017-12-07       Impact factor: 24.633

Review 6.  Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response.

Authors:  Katherine Y King; Margaret A Goodell
Journal:  Nat Rev Immunol       Date:  2011-09-09       Impact factor: 53.106

7.  BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.

Authors:  Jae-Seok Roe; Fatih Mercan; Keith Rivera; Darryl J Pappin; Christopher R Vakoc
Journal:  Mol Cell       Date:  2015-05-14       Impact factor: 17.970

8.  IFNalpha activates dormant haematopoietic stem cells in vivo.

Authors:  Marieke A G Essers; Sandra Offner; William E Blanco-Bose; Zoe Waibler; Ulrich Kalinke; Michel A Duchosal; Andreas Trumpp
Journal:  Nature       Date:  2009-02-11       Impact factor: 49.962

9.  CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials.

Authors:  V Ossipow; P Descombes; U Schibler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  CD34 and EPCR coordinately enrich functional murine hematopoietic stem cells under normal and inflammatory conditions.

Authors:  Jennifer L Rabe; Giovanny Hernandez; James S Chavez; Taylor S Mills; Claus Nerlov; Eric M Pietras
Journal:  Exp Hematol       Date:  2019-12-18       Impact factor: 3.084

View more
  3 in total

1.  C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations.

Authors:  Morito Kurata; Iichiro Onishi; Tomoko Takahara; Yukari Yamazaki; Sachiko Ishibashi; Ryo Goitsuka; Daisuke Kitamura; Junko Takita; Yasuhide Hayashi; David A Largaesapda; Masanobu Kitagawa; Takuro Nakamura
Journal:  Cancer Sci       Date:  2021-10-23       Impact factor: 6.716

2.  Hematopoietic stem and progenitor cells improve survival from sepsis by boosting immunomodulatory cells.

Authors:  Daniel E Morales-Mantilla; Bailee Kain; Duy Le; Anthony R Flores; Silke Paust; Katherine Y King
Journal:  Elife       Date:  2022-02-15       Impact factor: 8.140

3.  Role of lncRNA LIPE-AS1 in adipogenesis.

Authors:  Alyssa Thunen; Deirdre La Placa; Zhifang Zhang; John E Shively
Journal:  Adipocyte       Date:  2022-12       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.